The fourth most common form of cancer in women, it highlights some very well-characterized FGFR driver mutations, with up to 16% of cases driven by mutations in FGFR2 (Fearon et al., 2013, Pollock et al., 2007). This evidence concerns the gene FGFR2 and cancer.